サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1571459

腎不全治療市場規模、シェア、動向分析レポート：治療別、最終用途別、地域別、セグメント別予測、2024年～2030年

Renal Failure Treatment Market Size, Share & Trends Analysis Report By Treatment (Dialysis, Kidney Transplantation, Drug Therapy), By End-use (Hospitals, Specialty Clinics), By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
腎不全治療市場規模、シェア、動向分析レポート：治療別、最終用途別、地域別、セグメント別予測、2024年～2030年
出版日: 2024年09月04日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

腎不全治療市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の腎不全治療市場規模は2030年までに1,971億米ドルに達し、2024年から2030年までのCAGRは8.3％で成長すると予測されています。

この市場には、慢性腎臓病（CKD）や末期腎臓病（ESRD）の管理・治療を目的としたさまざまな製品やサービスが含まれます。

慢性腎臓病の有病率の増加は、重要な市場促進要因です。罹患率の増加は、腎臓病の危険因子として知られる糖尿病と高血圧の罹患率上昇に起因するところが大きいです。人口が高齢化し、これらの慢性疾患が蔓延するにつれ、腎不全治療の必要性は増大の一途をたどり、適切な治療を提供する医療システムへのさらなるプレッシャーとなっています。

腎臓の健康に対する認識と教育の高まりは、市場の重要な促進要因です。腎臓病のリスクや症状について個人を教育することを目的とした公衆衛生キャンペーンやイニシアチブは、早期診断と早期治療に貢献しています。意識の高まりは、患者がより早く医療機関に相談することを促し、最終的にはタイムリーな介入と腎臓疾患の管理改善につながります。

2023年10月、Zydus Lifesciences Limited and Sun Pharmaceutical Industries Limited (Sun Pharma) は、慢性腎臓病（CKD）による貧血を治療するインド初の経口薬であるDesidustatを共同販売するライセンス契約を締結しました。デシデュスタットのライセンス契約は、CKDに伴う貧血に対する新規の経口治療選択肢を提供し、患者ケアを強化し、インドにおける市場アクセスを拡大することで、同市場における重要な進展を意味します。

腎不全治療市場のレポートハイライト

  • 治療法別では、透析療法が2023年の売上高シェア72.34%で市場を独占。CKDとESRDの有病率の上昇が腎代替療法の需要を牽引しています。この動向の主な要因としては、人口の高齢化、透析技術の進歩、腎臓の健康に対する意識の高まりなどが挙げられます。
  • 最終用途別では、病院が2023年に57.64%の最大売上シェアで市場を独占しました。この成長を促進する要因としては、透析および移植処置のための患者入院の増加、腎ケア機器の技術進歩、複雑な症例に対応する病院が提供する包括的ヘルスケアサービスなどが挙げられます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 腎不全治療市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • 腎不全治療市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 腎不全治療市場：治療の推定・動向分析

  • 世界の腎不全治療市場：治療ダッシュボード
  • 世界の腎不全治療市場：治療変動分析
  • 世界の腎不全治療市場：治療、収益別
  • 透析
  • 腎臓移植
  • 薬物療法
  • その他

第5章 腎不全治療市場：最終用途の推定・動向分析

  • 世界の腎不全治療市場：最終用途ダッシュボード
  • 世界の腎不全治療市場：最終用途変動分析
  • 最終用途別、収益
  • 病院
  • 専門クリニック
  • その他

第6章 腎不全治療市場：治療・最終用途別、地域の推定と動向分析

  • 地域ダッシュボード
  • 市場規模と予測動向分析、2018年～2030年：
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第7章 競合情勢

  • 企業/競合の分類
  • ベンダー情勢
    • 主要販売代理店およびチャネルパートナーのリスト
    • Key company market share analysis, 2023
    • NIPRO
    • Fresenius Medical Care AG
    • Baxter
    • Medtronic
    • B. Braun SE
    • Asahi Kasei Medical Co., Ltd.
    • AbbVie Inc.
    • Nikkiso Co., Ltd.
    • JMS Co., Ltd.
    • AstraZeneca
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America renal failure treatment market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 4 North America renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 5 U.S. renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 6 U.S. renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 8 Canada renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Mexico renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 10 Mexico renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe renal failure treatment market, by region, 2018 - 2030 (USD Million)
  • Table 12 Europe renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 13 Europe renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Germany renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 15 Germany renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 16 UK renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 17 UK renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 18 France renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 19 France renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Italy renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 21 Italy renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Spain renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 23 Spain renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Denmark renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 25 Denmark renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Sweden renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 27 Sweden renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Norway renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 29 Norway renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific renal failure treatment market, by region, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 33 China renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 34 China renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Japan renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 36 Japan renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 37 India renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 38 India renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 39 South Korea renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 40 South Korea renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Australia renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 42 Australia renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Thailand renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 44 Thailand renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Latin America renal failure treatment market, by region, 2018 - 2030 (USD Million)
  • Table 46 Latin America renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 47 Latin America renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Brazil renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 49 Brazil renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Argentina renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 51 Argentina renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 52 MEA renal failure treatment market, by region, 2018 - 2030 (USD Million)
  • Table 53 MEA renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 54 MEA renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 55 South Africa renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 56 South Africa renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 59 UAE renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 60 UAE renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 62 Kuwait renal failure treatment market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modeling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 Renal failure treatment market: market outlook
  • Fig. 7 Renal failure treatment competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 Related/ancillary market outlook
  • Fig. 10 Renal failure treatment market driver impact
  • Fig. 11 Renal failure treatment market restraint impact
  • Fig. 12 Renal failure treatment market: Treatment movement analysis
  • Fig. 13 Renal failure treatment market: Treatment outlook and key takeaways
  • Fig. 14 Dialysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Hemodialysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Peritoneal dialysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Kidney transplantation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Drug therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Antihypertensive drugs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Antianemia therapeutics (erythropoiesis-stimulating agents) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Potassium binders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Phosphate binders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Renal failure treatment market: End use movement analysis
  • Fig. 25 Renal failure treatment market: End use outlook and key takeaways
  • Fig. 26 Hospital market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Specialty clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Global renal failure treatment market: Regional movement analysis
  • Fig. 30 Global renal failure treatment market: Regional outlook and key takeaways
  • Fig. 31 Global renal failure treatment market share and leading players
  • Fig. 32 North America, by country
  • Fig. 33 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. key country dynamics
  • Fig. 35 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Canada key country dynamics
  • Fig. 37 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico key country dynamics
  • Fig. 39 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 UK key country dynamics
  • Fig. 42 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Germany key country dynamics
  • Fig. 44 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 France key country dynamics
  • Fig. 46 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Italy key country dynamics
  • Fig. 48 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Spain key country dynamics
  • Fig. 50 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark key country dynamics
  • Fig. 52 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden key country dynamics
  • Fig. 54 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Norway key country dynamics
  • Fig. 56 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 China key country dynamics
  • Fig. 59 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Japan key country dynamics
  • Fig. 61 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 India key country dynamics
  • Fig. 63 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand key country dynamics
  • Fig. 65 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 South Korea key country dynamics
  • Fig. 67 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Australia key country dynamics
  • Fig. 69 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Brazil key country dynamics
  • Fig. 72 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Argentina key country dynamics
  • Fig. 74 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 South Africa key country dynamics
  • Fig. 77 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Saudi Arabia key country dynamics
  • Fig. 79 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 UAE key country dynamics
  • Fig. 81 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Kuwait key country dynamics
  • Fig. 83 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Market share of key market players- renal failure treatment market
目次
Product Code: GVR-4-68040-441-7

Renal Failure Treatment Market Growth & Trends:

The global renal failure treatment market size is anticipated to reach USD 197.1 billion by 2030 and is anticipated to grow at a CAGR of 8.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market encompasses a range of products and services designed to manage and treat chronic kidney disease (CKD) and end-stage renal disease (ESRD).

The increasing prevalence of chronic kidney disease is a significant market driver. The growing incidence is largely attributed to the rising rates of diabetes and hypertension, which are known risk factors for kidney disease. As the population ages and these chronic conditions become more prevalent, the need for renal failure treatment continues to grow, placing additional pressure on healthcare systems to provide adequate care.

Rising awareness and education about kidney health are crucial market drivers. Public health campaigns and initiatives aimed at educating individuals about the risks and symptoms of kidney disease have contributed to earlier diagnosis and treatment. The heightened awareness encourages patients to seek medical advice sooner, ultimately leading to timely interventions and improved management of kidney conditions.

In October 2023, Zydus Lifesciences Limited and Sun Pharmaceutical Industries Limited (Sun Pharma) entered a licensing agreement to co-commercialize Desidustat, the first oral drug in India to treat anemia caused by chronic kidney disease (CKD). The licensing agreement for Desidustat represents a significant development in the market by providing a novel oral treatment option for anemia associated with CKD, enhancing patient care, and expanding market access in India.

Renal Failure Treatment Market Report Highlights:

  • Based on treatment, dialysis dominated the market with the largest revenue share of 72.34% in 2023. The rising prevalence of CKD and ESRD is driving the demand for renal replacement therapies. Major factors contributing to this trend include an aging population, technological advancements in dialysis, and increased kidney health awareness
  • Based on end-use, hospitals dominated the market with the largest revenue share of 57.64% in 2023. Factors driving this growth include a rise in patient admissions for dialysis and transplant procedures, technological advancements in renal care equipment, and comprehensive healthcare services provided by hospitals that cater to complex cases

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Treatment Outlook
    • 2.2.2. End Use Outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Renal Failure Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increased prevalence of CKD
      • 3.2.1.2. Advancements in treatment technologies
      • 3.2.1.3. Rising awareness and education about kidney health
      • 3.2.1.4. Aging population
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of treatment
      • 3.2.2.2. Limited Healthcare Resources and Access
  • 3.3. Renal Failure Treatment Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Renal Failure Treatment Market: Treatment Estimates & Trend Analysis

  • 4.1. Global Renal Failure Treatment Market: Treatment Dashboard
  • 4.2. Global Renal Failure Treatment Market: Treatment Movement Analysis
  • 4.3. Global Renal Failure Treatment Market by Treatments, Revenue
  • 4.4. Dialysis
    • 4.4.1. Dialysis market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.2. Hemodialysis
      • 4.4.2.1. Hemodialysis market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.3. Peritoneal Dialysis
      • 4.4.3.1. Peritoneal Dialysis market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.5. Kidney Transplantation
    • 4.5.1. Kidney transplantation market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.6. Drug Therapy
    • 4.6.1. Drug therapy market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.6.2. Antihypertensive Drugs
      • 4.6.2.1. Antihypertensive Drugs market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.6.3. Antianemia Therapeutics (Erythropoiesis-Stimulating Agents)
      • 4.6.3.1. Antianemia therapeutics (Erythropoiesis-Stimulating Agents) market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.6.4. Potassium Binders
      • 4.6.4.1. Potassium Binders market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.6.5. Phosphate Binders
      • 4.6.5.1. Phosphate Binders market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Renal Failure Treatment Market: End Use Estimates & Trend Analysis

  • 5.1. Global Renal Failure Treatment Market: End Use Dashboard
  • 5.2. Global Renal Failure Treatment Market: End Use Movement Analysis
  • 5.3. Global Renal Failure Treatment Market Estimates and Forecasts, By End Use, Revenue (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.5. Specialty Clinics
    • 5.5.1. Specialty clinics market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Renal Failure Treatment Market: Regional Estimates & Trend Analysis by Treatment, and End Use

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Vendor Landscape
    • 7.2.1. List of key distributors and channel partners
    • 7.2.2. Key company market share analysis, 2023
    • 7.2.3. NIPRO
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Fresenius Medical Care AG
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Baxter
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Medtronic
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. B. Braun SE
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Asahi Kasei Medical Co., Ltd.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. AbbVie Inc.
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Nikkiso Co., Ltd.
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. JMS Co., Ltd.
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. AstraZeneca
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives